| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 749160 | Null | 0.0295480456086945 | 0.30160185 |
| NSC 751830 | 2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one | 0.0295480456086945 | 0.050185433 |
| NSC 753376 | 3-[4-(1H-indol-3-yl)-1,3-thiazol-2-yl]-1-methyl-1H-indole | 0.0295480456086945 | 0.28290449 |
| NSC 102051 | Null | 0.0295480456086947 | -0.050585489 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0295480456086947 | 0.12591229 |
| NSC 15795 | Null | 0.0295480456086947 | 0.1720174 |
| NSC 168516 | Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- | 0.0295480456086947 | 0.50682484 |
| NSC 175493 | Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- | 0.0295480456086947 | 0.35934729 |
| NSC 176328 | Ellipticine, 6-(3-aminopropyl)-, dihydrochloride | 0.0295480456086947 | 0.15608093 |
| NSC 208885 | Null | 0.0295480456086947 | 0.090469532 |